Skip to content

The effect of Gabapentin on the pain after inguinal hernia repair surgery

Evaluation the effect of Gabapentin on the pain after inguinal hernia repair surgery in general anesthesia

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190219042753N1
Enrollment
60
Registered
2020-08-21
Start date
2020-08-31
Completion date
Unknown
Last updated
2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Indirect inguinal hernia. Unilateral inguinal hernia, without obstruction or gangrene, not specified as recurrent

Interventions

Intervention 1: Intervention group: Gabapentin capsules (Caspian Drug Company of Rasht) with a dose of 400 mg will be prescribed as a single dose one hour before surgery. Intervention 2: Control group

Sponsors

Islamic Azad University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Unilateral indirect inguinal hernia Consent to enter the study Indication of hernia repair surgery under general anesthesia

Exclusion criteria

Exclusion criteria: Coagulation disorders Psychological and memory disorders Height less than 145 cm Weight more than 100 kg History of alcohol or drug abuse History of taking antacid drugs containing aluminum and magnesium Known allergy to gabapentin

Design outcomes

Primary

MeasureTime frame
Pain after surgery. Timepoint: One and eight hours after surgery. Method of measurement: Visual Analogue Scale.

Secondary

MeasureTime frame
Complications of anesthesia include nausea and vomiting. Timepoint: One and eight hours after surgery. Method of measurement: Asking from patient and recording in the checklist.;Duration of hospitalization. Timepoint: At the time of discharging. Method of measurement: Checking the file and recording in the checklist.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarzaneh Rahchamani

Islamic Azad University

Farzaneh.rah.chamani.2020@gmail.com+98 23 3239 4530

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026